Breathable Tint 4
Titanium Dioxide And Zinc Oxide
Quura Medical B.v
Human Otc Drug
NDC 51790-303Breathable Tint 4 also known as Titanium Dioxide And Zinc Oxide is a human otc drug labeled by 'Quura Medical B.v'. National Drug Code (NDC) number for Breathable Tint 4 is 51790-303. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Breathable Tint 4 drug includes Titanium Dioxide - 64 mg/mL Zinc Oxide - 86 mg/mL . The currest status of Breathable Tint 4 drug is Active.
Drug Information:
| Drug NDC: | 51790-303 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Breathable Tint 4 |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Titanium Dioxide And Zinc Oxide |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Quura Medical B.v |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | TITANIUM DIOXIDE - 64 mg/mL
ZINC OXIDE - 86 mg/mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 23 Dec, 2017 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 24 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part352 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Quura Medical B.V
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 8718226880208
|
| UPC stands for Universal Product Code. |
| UNII: | 15FIX9V2JP
SOI2LOH54Z
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
| Pharmacologic Class: | Copper Absorption Inhibitor [EPC]
Decreased Copper Ion Absorption [PE]
|
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 51790-303-01 | 30 mL in 1 TUBE (51790-303-01) | 09 Jan, 2018 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Product Elements:
Breathable tint 1 titanium dioxide and zinc oxide zinc oxide zinc cation titanium dioxide titanium dioxide dimethicone bismuth oxychloride polyglyceryl-3 polydimethylsiloxyethyl dimethicone (4000 mpa.s) water mica cetyl peg/ppg-10/1 dimethicone (hlb 4) hydroxypropylcocoate peg-8 dimethicone polyglyceryl-2 diisostearate stearic acid aluminum hydroxide dimethicone/vinyl dimethicone crosspolymer (soft particle) glycerin saccharomyces lysate cyclomethicone 6 hyaluronate sodium sandalwood chlorella vulgaris centella asiatica artemisia vulgaris whole isohexadecane hydrated silica apple barley lonicera japonica flower peg/ppg-18/18 dimethicone xanthan gum lecithin, soybean cyperus rotundus root xanthium sibiricum whole omega-3 fatty acids olea europaea leaf mannitol sodium benzoate ascorbyl palmitate vitamin a palmitate squalane zinc pidolate sodium citrate acetyl tetrapeptide-15 tocopherol triethoxycaprylylsilane phellodendron amurense bark .beta.-carotene phenoxyethanol ethylhexylglycerin hexylene glycol caprylyl glycol ferric oxide red titanium dioxide iron oxides breathable tint 2 titanium dioxide and zinc oxide zinc oxide zinc cation titanium dioxide titanium dioxide dimethicone bismuth oxychloride polyglyceryl-3 polydimethylsiloxyethyl dimethicone (4000 mpa.s) water mica cetyl peg/ppg-10/1 dimethicone (hlb 4) hydroxypropylcocoate peg-8 dimethicone polyglyceryl-2 diisostearate stearic acid aluminum hydroxide dimethicone/vinyl dimethicone crosspolymer (soft particle) glycerin saccharomyces lysate cyclomethicone 6 hyaluronate sodium sandalwood chlorella vulgaris centella asiatica artemisia vulgaris whole isohexadecane hydrated silica apple barley lonicera japonica flower peg/ppg-18/18 dimethicone xanthan gum lecithin, soybean cyperus rotundus root xanthium sibiricum whole omega-3 fatty acids olea europaea leaf mannitol sodium benzoate ascorbyl palmitate vitamin a palmitate squalane zinc pidolate sodium citrate acetyl tetrapeptide-15 tocopherol triethoxycaprylylsilane phellodendron amurense bark .beta.-carotene phenoxyethanol ethylhexylglycerin hexylene glycol caprylyl glycol titanium dioxide iron oxides breathable tint 3 titanium dioxide and zinc oxide zinc oxide zinc cation titanium dioxide titanium dioxide dimethicone bismuth oxychloride polyglyceryl-3 polydimethylsiloxyethyl dimethicone (4000 mpa.s) water mica cetyl peg/ppg-10/1 dimethicone (hlb 4) hydroxypropylcocoate peg-8 dimethicone polyglyceryl-2 diisostearate stearic acid aluminum hydroxide dimethicone/vinyl dimethicone crosspolymer (soft particle) glycerin saccharomyces lysate cyclomethicone 6 hyaluronate sodium sandalwood chlorella vulgaris centella asiatica artemisia vulgaris whole isohexadecane hydrated silica apple barley lonicera japonica flower peg/ppg-18/18 dimethicone xanthan gum lecithin, soybean cyperus rotundus root xanthium sibiricum whole omega-3 fatty acids olea europaea leaf mannitol sodium benzoate ascorbyl palmitate vitamin a palmitate squalane zinc pidolate sodium citrate acetyl tetrapeptide-15 tocopherol triethoxycaprylylsilane phellodendron amurense bark .beta.-carotene phenoxyethanol ethylhexylglycerin hexylene glycol caprylyl glycol titanium dioxide ironoxides breathable tint 4 titanium dioxide and zinc oxide zinc oxide zinc cation titanium dioxide titanium dioxide dimethicone bismuth oxychloride polyglyceryl-3 polydimethylsiloxyethyl dimethicone (4000 mpa.s) water mica cetyl peg/ppg-10/1 dimethicone (hlb 4) hydroxypropylcocoate peg-8 dimethicone polyglyceryl-2 diisostearate stearic acid aluminum hydroxide dimethicone/vinyl dimethicone crosspolymer (soft particle) glycerin saccharomyces lysate cyclomethicone 6 hyaluronate sodium sandalwood chlorella vulgaris centella asiatica artemisia vulgaris whole isohexadecane hydrated silica apple barley lonicera japonica flower peg/ppg-18/18 dimethicone xanthan gum lecithin, soybean cyperus rotundus root xanthium sibiricum whole omega-3 fatty acids olea europaea leaf mannitol sodium benzoate ascorbyl palmitate vitamin a palmitate squalane zinc pidolate sodium citrate acetyl tetrapeptide-15 tocopherol triethoxycaprylylsilane phellodendron amurense bark .beta.-carotene phenoxyethanol ethylhexylglycerin hexylene glycol caprylyl glycol titanium dioxide iron oxides
Package Label Principal Display Panel:
Product label almond shade tube label 1
Tube label2
Outer label
Image description